Ritonavir Active Not Recruiting Phase 2 Trials for Hepatitis D / Liver Diseases Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03600714Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon